Boston Scientific and Arterial Vascular Engineering bidding for Schneider
This article was originally published in Clinica
Executive Summary
Boston Scientific and Arterial Vascular Engineering may be prepared to pay around $2 billion for Schneider Worldwide, the angioplasty device manufacturer Pfizer put up for sale earlier this year.